Produktname:2-(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)ethan-1-amine hydrochloride

IUPAC Name:2-(2,3-dihydro-1,4-benzodioxin-2-yl)ethan-1-amine hydrochloride

CAS:2165-35-7
Molekulare Formel:C10H14ClNO2
Reinheit:95%
Katalognummer:CM124544
Molekulargewicht:215.68

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM124544-1g in stock ȀǕȀ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:2165-35-7
Molekulare Formel:C10H14ClNO2
Schmelzpunkt:-
SMILES-Code:NCCC1COC2=CC=CC=C2O1.[H]Cl
Dichte:
Katalognummer:CM124544
Molekulargewicht:215.68
Siedepunkt:
Mdl-Nr.:MFCD09701224
Lagerung:

Category Infos

Benzodioxanes
Benzodioxanes are a class of isomeric compounds with the molecular formula C8H8O2. The three isomers of benzodioxane are 1,2-benzodioxane, 1,3-benzodioxane and 1,4-benzodioxane. 1,4-Benzodioxane has long been a versatile template widely used to design molecules with diverse biological activities. Its use spans past decades in medicinal chemistry to today, involving many drug discovery strategies, not excluding the most advanced ones. 1,4-Benzodioxane derivatives have been described as agonists and antagonists of nicotinic, alpha-adrenergic and 5-HT receptor subtypes. 1,4-Benzodioxane derivatives have been also reported as antitumor and antibacterial agents.

Column Infos

Benzo Heterocycles
Benzoheterocycles are heterocycles which are fused with a benzene ring. Coumarone, thianaphthene, benzopyridine, isoquinoline, and dibenzopyridine all belong to this class of compounds.

Related Products



Product Other Information

Product Overview 2-(2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)ethanamine hydrochloride, commonly known as DBED, is a chemical compound that has gained significant attention in the scientific community due to its potential therapeutic applications. DBED is a synthetic compound that belongs to the family of phenethylamines and is structurally similar to the neurotransmitter serotonin.
Synthesis Method The synthesis of DBED involves the reaction of 2,3-dihydrobenzo[b][1,4]dioxine with ethylenediamine in the presence of hydrochloric acid. The reaction yields DBED as a hydrochloride salt, which is a white crystalline powder. The purity of DBED can be increased by recrystallization from ethanol.
Synthesis and Application DBED has been extensively studied for its potential therapeutic applications. It has been shown to have a high affinity for the serotonin transporter, which makes it a potential candidate for the treatment of depression and anxiety disorders. DBED has also been shown to have neuroprotective properties, which makes it a potential candidate for the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's disease.
Future Directions One direction is to conduct clinical trials to determine its safety and efficacy for the treatment of depression, anxiety disorders, and neurodegenerative diseases. Another direction is to study the mechanism of action of DBED in more detail to understand how it interacts with the serotonin transporter and the 5-HT1A receptor. Additionally, the synthesis of DBED derivatives with improved pharmacological properties should be explored.